HLOC yields 425.53% · ABBV yields 3.06%● Live data
📍 HLOC pulled ahead of the other in Year 1
Combined, HLOC + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HLOC + ABBV for your $10,000?
Helo Corp., a wellness technology company, provides wearable devices for use in the quantified-self wellness market. The company's wearable devices and related applications offer its end-users with health-related knowledge acquired through self-tracking. It offers VYYO Vista, which captures data that can be used to analyze resting and exercising heart rates, blood pressure estimation, breath rate, and energy levels, as well as provide insights into mood and sleep; and VYVO Sense, a smartband with 6 axes movement detection and an electrocardiogram (ECG) sensor. The company also provides VYVO Icon, a smartwatch that enables data to be collected to allow third parties to deduce parameters, such as body fat percentage, visceral fat levels, muscle, and bone mass; gather data to generate a third-party representation of an ECG; and provide continuous detection of possible irregular heartbeats comprising an atrial fibrillation or other arrhythmias. In addition, it offers VYVO Leggera, a smart weighing scale that can measure body weight, and has a BI sensor to capture data used to deduce bone weight, visceral fat, and body mass index; VYVO Vista+; and VYVO Watch Lite, which has data collection capabilities that enable features, including continuous atrial fibrillation detection, mood, and energy monitoring, as well as fall detection, SpO2 measurement capability, and sleep apnea detection. Further, it provides VYVO Watch Lite SE, which offers a body temperature result with an accuracy of up to ±0.1°C; and VYVO Watch Generation 2, a watch that enables medical-grade measurements with enhanced data accuracy for blood oxygen measurements, vascular aging, and ECGs. Helo Corp. sells its products through its marketing and distribution partner, VYVO HK Ltd., and its distribution network. The company was formerly known as World Technology Corp. and changed its name to Helo Corp. in October 2018. Helo Corp. was incorporated in 2010 and is headquartered in San Francisco, California.
Full HLOC Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.